中國醫藥大學機構典藏 China Medical University Repository, Taiwan:Item 310903500/29076
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 29490/55136 (53%)
造訪人次 : 1562306      線上人數 : 281
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於CMUR管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/29076


    題名: Facile synthesis of metal-chelating peptides on chip for protein array
    作者: Cheng, CW;Lin, KC;Pan, FM;Sinchaikul, S;Wong, CH;Su, WC;Hsu, CH;Chen, ST
    貢獻者: 附設醫院內科部風濕免疫科;ALPS Biotech Co Ltd, Taipei, Taiwan;Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan;Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan;Genmont Biotech Inc, Tainan 741, Taiwan;China Med Univ, Allergy Immunol & Rheumatol Dept, Div Pediat, Taichung 404, Taiwan
    日期: 2004
    上傳時間: 2010-09-24 14:20:42 (UTC+8)
    出版者: PERGAMON-ELSEVIER SCIENCE LTD
    摘要: The clinical outcome for methamphetamine (MAP) abusers is variable. MAP exerts its biological activity through rapid conversion to amphetamine (AP) and MAP itself. The dopamine transporter (DAT) is the main modulator of MAP/ AP-induced dopamine release and dopamine neurotoxicity, and is also the major regulator of dopamine level in the brain. We tested for an association between a DAT-gene polymorphism and clinical variations in MAP abusers. A total of 146 MAP abusers were enrolled in the study and classified into three clinically distinct groups: MAP dependence (n=30), MAP psychosis (n=88) and chronic MAP psychosis (n = 28). Patients with schizophrenic (n = 79) and healthy controls (n = 72) were also recruited for the study. The 40 base pair variable number tandem repeat polymorphism in the 3'-untranslated region of the DAT was the focus of the investigation. The subjects were all Chinese residents of Taiwan. The respective allelic frequencies for DAT repeats 11, 10 and 9 were 0.067, 0.833 and 0.083 for the MAP-dependence group, 0.006, 0.864 and 0.119 for the MAP psychosis group, 0.018, 0.893 and 0.089 for the chronic MAP psychosis group, 0.019, 0.911 and 0.07 for the schizophrenic controls, and 0.021, 0.889 and 0.083 for the healthy controls. No significant associations were demonstrated between this DAT polymorphism in genotype and allele frequency and the clinical outcome of MAP abusers. The biological relevance of the variable number tandem repeat polymorphism in the 3'-untranslated region of DAT in MAP abusers was not demonstrated in this study. Psychiatr Genet 14:33-37 (C) 2004 Lippincott Williams Wilkins.
    關聯: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 14(8):1987-1990
    顯示於類別:[台中附設醫院] 期刊論文

    文件中的檔案:

    沒有與此文件相關的檔案.



    在CMUR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋